In this issue: the clinical promise of Intravascular Lithotripsy, (IVL), the impact of Trump's tariffs on the MedTech ...

British healthtech company Huma Therapeutics has initiated the global launch of Hi Scribe, a generative AI (genAI) clinical ...

Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney ...

RadNet, a DeepHealth company, has acquired See-Mode, an artificial intelligence (AI)-based ultrasound imaging developer. The ...

Arthrex has introduced Synergy Power, a new battery-powered solution tailored for a broad spectrum of orthopaedic procedures.

Reports have emerged that the European Union (EU) has voted to ban Chinese companies from participating in public procurement ...

The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a ...

Brain-computer interface (BCI) technology developer Cognixion, and eye-tracking platform specialist Pupil Lab, have forged a ...

Johnson & Johnson MedTech has introduced the KINCISE 2 Surgical Automated System, intended for use in knee and hip revision ...

Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Food and Drug Administration’s (FDA) ...

New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA ...